Press Release

Viamet Pharmaceuticals To Present at the 31st Annual J.P. Morgan Healthcare Conference

January 3, 2013

Press Release

Viamet Pharmaceuticals Announces Agreement with NIAID to Advance Novel Class of Broad-Spectrum Antifungal Compounds

June 19, 2012

Press Release

Viamet Pharmaceuticals Appoints Richard Katz, M.D. as Chief Business and Financial Officer

March 7, 2012

Press Release

Viamet Pharmaceuticals Initiates Phase 1/2 Clinical Trial of Novel Prostate Cancer Therapy, VT-464

January 4, 2012

Press Release

Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer

November 3, 2011

Press Release

Viamet Pharmaceuticals Initiates Phase 1 Clinical Program with Novel Antifungal Agent VT-1161

September 9, 2011

Press Release

Viamet Pharmaceuticals and the National Institutes of Health to Jointly Develop Novel Viamet Compound

July 28, 2011

Press Release

Andrew von Eschenbach, M.D., Former FDA Commissioner and Leading Prostate Cancer Expert, Elected to Viamet Pharmaceuticals Board of Directors

January 19, 2011

Press Release

Viamet Pharmaceuticals, Dow AgroSciences to Collaborate on Development of Improved Crop Protection Products

November 2, 2010

Press Release

Viamet Pharmaceuticals and the Novartis Option Fund Enter Agreement for Development of Novel Metalloenzyme Inhibitors

February 22, 2010

Press Release

Viamet Pharmaceuticals Names William Moore, Ph.D. as CSO

January 11, 2010

Article

Drug Maker Viamet Raises $18 Million

July 8, 2009

Press Release

Viamet Pharmaceuticals Secures $18 Million Financing

July 7, 2009

Article

Viamet Gets Big Pharma Support in 18M Round

July 7, 2009